Catalyst Wire Dossier Catalyst Wire Dossier

BXQ-350

· Bexion Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BXQ-350, covering 2024-12-20 to 2025-01-27. Get the full timeline:

Most recent: Clinical Trial Update: BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients [EARLY_Phase 1]

See pricing